Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Isolere Bio is a Healthcare Company provides manufacturing solutions,facilitate therapeutic developments.
Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.
NabGen, Inc. is an NC based biotech company developing an antibody suppression platform with broad applications.
Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.
RainBio, a pioneer in ocular gene therapy, focuses on corneal blindness.
EncepHeal Therapeutics enhances the development of first-in-class medicines to improve treatment of mental health disorders.
IngateyGen is a biotech company that concentrates on human nutrition.
Baebies develops early disease detection and comprehensive diagnostic solutions.
QATCH Technologies company that’s developing a tool to determine the injectability and manufacturability of biopharmaceutical products.
Personalized Precision Medications combined into one capsule or gel packet
Renaissance Fiber produces high quality textile and technical fibers and yarns manufactured from industrial hemp.
BiomedInnovations are developing technologies for long-term storage and interaction with large tissues and organs outside of the human body.
Lindy Biosciences is a development-stage protein therapeutic formulations company.
Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine.
Phase provides 3D-printing medical devices for microfluidics.
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.
Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia.
InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.
Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.
The digestive health platform of the future
IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.
Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.
North Carolina Biotechnology Center has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
North Carolina Biotechnology Center's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 25 different industry categories.
Among tracked funding rounds, Baebies received $37.5M in a Venture - Series Unknown round. North Carolina Biotechnology Center's total known invested capital is $34.4M.
North Carolina Biotechnology Center's average investment size is $929K across its portfolio of 57 companies.
Recent North Carolina Biotechnology Center portfolio additions include Isolere Bio, Drive Therapeutics, Dignify Therapeutics, Belhaven Biopharma, NabGen, Inc.. These companies were founded in 2020 or later.